Skip to main content

Market Overview

Gattex

  • AMR101, AMRN, Gattex, HZNP, IRWD, Kyprolis

    Biotechs With Upcoming PDUFA Dates

    Wednesday, July 18, 2012 - 3:09pm

    On Tuesday, the FDA approved the second weight-loss drug in the last 13 years when it green-lighted Vivus' drug Qsymia. On Wednesday, VVUS shares have shot up more than 14 percent to $30.27. The approval of this drug and the excitement that it has created in the biotech investing community may...

    Read More...